glp-1 receptor agonist type 1 diabetes trial liraglutide Agonists and Research to Treat Overeating and Substance Use Disorders GLP-1 Receptor Agonists as Treatments

The primary analysis included all patients with at least one follow-up visit after the index date

This combined approach has been shown in studies to support long-term weight management in eligible individuals

Additionally, vascular endothelium becomes less effective at regulating blood flow and preventing clot formation, leading to endothelial dysfunction, increasing the risk of atherosclerosis, thrombosis, and other vascular diseases

sulfonylureas, meglitinides), liraglutide increases the risk of hypoglycemia

doi: 10.1016/j.ejphar.2008.03.025 [DOI] [PubMed] [Google Scholar] 172

The last two and a half years, however, have been promising for medical weight management